Nifty

:

17629.50

Sensex

:

59141.16

110.05 (0.63%)
417.96 (0.71%)

Login

Nifty
Sensex

:
:

17629.50
59141.16

110.05 (0.63%)
417.96 (0.71%)

Morepen Laboratories Ltd.

Pharmaceuticals & Drugs - API

Rating :

56/99

BSE: 500288 | NSE: MOREPENLAB

Watchlist

NSE BSE

57.85

16-Sep-2021

Open
High
Low
Previous Close

59.55
59.70
57.60
59.25

Volume
Traded Value (lacs)
52 Week High
52 Week Low

1460427
849.32
75.00
22.35

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

2,665.22
24.63
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

2,759.46
N/A
5.85

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

14.09
11.95
12.04

EBITDA CAGR (%)

10 Years
5 Years
3 Years

28.07
2.17
1.14

PAT CAGR (%)

10 Years
5 Years
3 Years

-
21.28
4.31

P:E (Median)

8 Years
5 Years
3 Years

31.05
31.25
25.31

P:BV (Average)

8 Years
5 Years
3 Years

4.20
4.56
3.87

EV:EBITDA (Average)

8 Years
5 Years
3 Years

14.68
15.15
13.11

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 21 Jun 20 Var% Mar 21 Mar 20 Var% Dec 20 Dec 19 Var% Sep 20 Sep 19 Var%
Net Sales 365.23 243.26 50.14% 264.11 189.15 39.63% 290.46 213.49 36.05% 314.60 199.88 57.39%
Expenses 322.59 217.98 47.99% 236.45 172.80 36.83% 260.35 199.71 30.36% 285.27 184.99 54.21%
EBITDA 42.64 25.27 68.74% 27.65 16.35 69.11% 30.11 13.77 118.66% 29.33 14.90 96.85%
EBIDTM 11.68% 10.39% 10.47% 8.64% 10.37% 6.45% 9.32% 7.45%
Other Income 1.58 1.33 18.80% 3.87 1.72 125.00% 2.84 4.60 -38.26% 3.73 2.81 32.74%
Interest 0.21 0.29 -27.59% -0.05 0.62 - 1.27 0.54 135.19% 0.29 0.39 -25.64%
Depreciation 5.40 7.47 -27.71% 6.43 7.97 -19.32% 7.05 7.93 -11.10% 7.15 7.63 -6.29%
PBT 38.62 18.84 104.99% 25.14 9.48 165.19% 24.64 9.90 148.89% 25.62 9.69 164.40%
Tax 7.77 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 5.15 -100.00%
PAT 30.85 18.84 63.75% 25.14 9.48 165.19% 24.64 9.90 148.89% 25.62 4.54 464.32%
PATM 8.45% 7.75% 9.52% 5.01% 8.48% 4.64% 8.14% 2.27%
EPS 0.69 0.42 64.29% 0.56 0.21 166.67% 0.55 0.22 150.00% 0.57 0.10 470.00%

Description Jun 21 Jun 20 Var% Mar 21 Mar 20 Var% Dec 20 Dec 19 Var% Sep 20 Sep 19 Var%
Net Sales 386.73 257.64 50.10% 286.60 206.60 38.72% 307.42 230.06 33.63% 336.39 213.43 57.61%
Expenses 342.88 231.07 48.39% 256.20 187.78 36.44% 277.63 214.75 29.28% 304.64 198.37 53.57%
EBITDA 43.85 26.57 65.04% 30.40 18.83 61.44% 29.79 15.30 94.71% 31.75 15.06 110.82%
EBIDTM 11.34% 10.31% 10.61% 9.11% 9.69% 6.65% 9.44% 7.05%
Other Income 1.58 1.33 18.80% 4.16 1.79 132.40% 2.84 4.60 -38.26% 3.73 2.81 32.74%
Interest 0.21 0.29 -27.59% -0.05 0.62 - 1.27 0.54 135.19% 0.29 0.39 -25.64%
Depreciation 6.69 8.06 -17.00% 6.98 8.63 -19.12% 7.56 8.54 -11.48% 7.68 8.24 -6.80%
PBT 38.53 19.55 97.08% 27.64 11.36 143.31% 23.80 10.82 119.96% 27.52 9.24 197.84%
Tax 8.06 0.19 4,142.11% 0.87 0.34 155.88% 0.01 0.01 0.00% 0.35 5.15 -93.20%
PAT 30.47 19.37 57.31% 26.76 11.02 142.83% 23.79 10.82 119.87% 27.17 4.09 564.30%
PATM 7.88% 7.52% 9.34% 5.33% 7.74% 4.70% 8.08% 1.92%
EPS 0.68 0.43 58.14% 0.59 0.25 136.00% 0.53 0.24 120.83% 0.60 0.09 566.67%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 1,234.40 791.99 717.24 560.83 547.51 452.46 370.26 335.97 303.35 269.50 216.31 Net Sales Growth 45.95% 10.42% 27.89% 2.43% 21.01% 22.20% 10.21% 10.75% 12.56% 24.59% Cost Of Goods Sold 827.76 487.87 448.98 335.30 328.24 273.04 223.63 194.39 185.79 172.43 140.48 Gross Profit 406.64 304.13 268.26 225.52 219.27 179.42 146.64 141.58 117.56 97.07 75.83 GP Margin 32.94% 38.40% 37.40% 40.21% 40.05% 39.65% 39.60% 42.14% 38.75% 36.02% 35.06% Total Expenditure 1,104.66 727.52 652.22 500.56 487.02 388.26 323.68 290.16 274.37 251.87 209.07 Power & Fuel Cost - 12.56 13.18 11.08 9.84 7.64 7.41 8.42 8.96 9.82 7.69 % Of Sales - 1.59% 1.84% 1.98% 1.80% 1.69% 2.00% 2.51% 2.95% 3.64% 3.56% Employee Cost - 98.07 84.74 68.22 60.79 51.67 43.52 39.16 34.47 32.12 26.79 % Of Sales - 12.38% 11.81% 12.16% 11.10% 11.42% 11.75% 11.66% 11.36% 11.92% 12.39% Manufacturing Exp. - 48.90 31.27 16.21 15.05 13.33 12.63 12.23 11.33 11.34 11.40 % Of Sales - 6.17% 4.36% 2.89% 2.75% 2.95% 3.41% 3.64% 3.73% 4.21% 5.27% General & Admin Exp. - 31.93 31.21 24.35 21.53 15.34 13.77 14.60 11.43 12.18 10.06 % Of Sales - 4.03% 4.35% 4.34% 3.93% 3.39% 3.72% 4.35% 3.77% 4.52% 4.65% Selling & Distn. Exp. - 35.75 31.72 29.13 29.04 19.87 16.06 15.11 15.48 10.51 8.27 % Of Sales - 4.51% 4.42% 5.19% 5.30% 4.39% 4.34% 4.50% 5.10% 3.90% 3.82% Miscellaneous Exp. - 12.45 11.11 16.26 22.53 7.38 6.66 6.25 6.91 3.47 8.27 % Of Sales - 1.57% 1.55% 2.90% 4.11% 1.63% 1.80% 1.86% 2.28% 1.29% 2.02% EBITDA 129.73 64.47 65.02 60.27 60.49 64.20 46.58 45.81 28.98 17.63 7.24 EBITDA Margin 10.51% 8.14% 9.07% 10.75% 11.05% 14.19% 12.58% 13.64% 9.55% 6.54% 3.35% Other Income 12.02 9.42 3.67 3.54 3.72 1.17 1.36 0.79 2.62 1.02 1.04 Interest 1.72 1.97 2.07 4.29 7.47 10.41 8.63 9.89 11.61 7.96 6.23 Depreciation 26.03 34.43 38.01 33.40 33.56 34.92 38.59 45.77 45.74 46.89 45.78 PBT 114.02 37.48 28.61 26.12 23.17 20.04 0.72 -9.06 -25.75 -36.20 -43.73 Tax 7.77 5.15 0.00 0.00 0.00 -0.14 0.14 0.00 0.00 0.00 -0.75 Tax Rate 6.81% 13.74% 0.00% 0.00% 0.00% -0.90% 19.44% 0.00% 0.00% 0.00% 1.72% PAT 106.25 32.33 28.61 26.12 23.17 15.78 0.58 -6.16 -22.67 -24.16 -42.98 PAT before Minority Interest 106.25 32.33 28.61 26.12 23.17 15.78 0.58 -6.16 -22.67 -24.16 -42.98 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 8.61% 4.08% 3.99% 4.66% 4.23% 3.49% 0.16% -1.83% -7.47% -8.96% -19.87% PAT Growth 148.48% 13.00% 9.53% 12.73% 46.83% 2,620.69% - - - - EPS 2.36 0.72 0.64 0.58 0.52 0.35 0.01 -0.14 -0.50 -0.54 -0.96

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 1,317.14 853.07 768.54 606.51 595.47 485.08 400.64 366.85 325.92 289.34 228.30 Net Sales Growth 45.10% 11.00% 26.72% 1.85% 22.76% 21.08% 9.21% 12.56% 12.64% 26.74% Cost Of Goods Sold 876.44 524.19 479.12 361.28 358.35 293.33 238.62 209.04 193.53 178.07 142.68 Gross Profit 440.70 328.87 289.42 245.23 237.12 191.76 162.02 157.81 132.39 111.27 85.62 GP Margin 33.46% 38.55% 37.66% 40.43% 39.82% 39.53% 40.44% 43.02% 40.62% 38.46% 37.50% Total Expenditure 1,181.35 784.55 701.02 541.78 534.09 423.52 352.41 317.95 294.97 270.11 222.53 Power & Fuel Cost - 12.56 13.18 11.08 9.84 7.64 7.41 8.42 8.96 9.82 7.69 % Of Sales - 1.47% 1.71% 1.83% 1.65% 1.57% 1.85% 2.30% 2.75% 3.39% 3.37% Employee Cost - 109.91 95.36 76.53 69.69 58.29 48.79 45.08 39.17 36.05 30.52 % Of Sales - 12.88% 12.41% 12.62% 11.70% 12.02% 12.18% 12.29% 12.02% 12.46% 13.37% Manufacturing Exp. - 48.92 31.28 16.21 22.36 13.33 12.68 12.23 11.33 10.20 11.40 % Of Sales - 5.73% 4.07% 2.67% 3.76% 2.75% 3.16% 3.33% 3.48% 3.53% 4.99% General & Admin Exp. - 36.47 36.14 28.52 18.11 18.14 15.89 16.62 13.86 14.37 12.72 % Of Sales - 4.28% 4.70% 4.70% 3.04% 3.74% 3.97% 4.53% 4.25% 4.97% 5.57% Selling & Distn. Exp. - 40.11 32.73 30.04 25.79 23.45 21.40 19.55 20.40 15.85 11.26 % Of Sales - 4.70% 4.26% 4.95% 4.33% 4.83% 5.34% 5.33% 6.26% 5.48% 4.93% Miscellaneous Exp. - 12.39 13.20 18.11 29.95 9.35 7.61 7.01 7.72 5.75 11.26 % Of Sales - 1.45% 1.72% 2.99% 5.03% 1.93% 1.90% 1.91% 2.37% 1.99% 2.74% EBITDA 135.79 68.52 67.52 64.73 61.38 61.56 48.23 48.90 30.95 19.23 5.77 EBITDA Margin 10.31% 8.03% 8.79% 10.67% 10.31% 12.69% 12.04% 13.33% 9.50% 6.65% 2.53% Other Income 12.31 9.48 3.67 3.72 3.72 1.20 1.37 1.22 2.87 1.18 1.04 Interest 1.72 1.98 2.11 4.36 7.56 10.50 8.66 9.92 11.63 7.96 6.27 Depreciation 28.91 36.91 39.90 34.32 33.90 35.20 38.67 45.84 45.80 48.06 48.16 PBT 117.49 39.11 29.18 29.77 23.63 17.06 2.28 -5.64 -23.61 -35.61 -47.62 Tax 9.29 5.53 0.34 0.00 0.00 -0.13 0.14 0.01 -0.01 0.06 -0.69 Tax Rate 7.91% 14.14% 1.17% 0.00% 0.00% -1.03% 6.14% -0.36% 0.05% -0.25% 1.45% PAT 108.19 33.58 28.85 29.59 23.63 12.80 2.14 -2.77 -20.52 -23.65 -46.93 PAT before Minority Interest 108.18 33.58 28.84 29.77 23.63 12.80 2.14 -2.75 -20.52 -23.63 -46.93 Minority Interest -0.01 0.00 0.01 -0.18 0.00 0.00 0.00 -0.02 0.00 -0.02 0.00 PAT Margin 8.21% 3.94% 3.75% 4.88% 3.97% 2.64% 0.53% -0.76% -6.30% -8.17% -20.56% PAT Growth 138.83% 16.40% -2.50% 25.22% 84.61% 498.13% - - - - EPS 2.41 0.75 0.64 0.66 0.53 0.28 0.05 -0.06 -0.46 -0.53 -1.04

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 307.25 277.46 250.56 224.34 328.85 313.08 324.26 330.42 353.09 377.26 Share Capital 89.96 89.96 89.96 89.96 209.61 209.61 209.61 209.61 209.61 209.61 Total Reserves 217.29 187.50 160.60 134.38 119.24 103.47 114.65 120.81 143.48 167.65 Non-Current Liabilities 25.36 21.11 17.87 15.28 55.22 72.69 84.05 103.36 121.93 134.86 Secured Loans 0.92 1.79 2.70 0.94 42.74 62.22 74.65 94.49 98.85 114.37 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 15.04 14.32 Long Term Provisions 22.38 17.85 13.45 12.69 10.71 8.71 7.35 6.78 5.60 3.75 Current Liabilities 329.38 320.82 322.21 308.19 150.78 114.44 99.58 107.72 107.69 103.74 Trade Payables 158.38 157.08 164.89 116.20 107.48 78.55 66.75 54.90 63.59 57.32 Other Current Liabilities 157.39 153.61 156.05 190.70 39.14 32.82 30.91 52.14 43.20 44.68 Short Term Borrowings 11.36 8.99 0.00 0.00 0.00 2.23 1.19 0.00 0.00 0.00 Short Term Provisions 2.25 1.14 1.26 1.29 4.16 0.84 0.73 0.68 0.90 1.74 Total Liabilities 661.99 619.39 590.64 547.81 534.85 500.21 507.89 541.50 582.71 615.86 Net Block 134.84 152.59 182.10 191.29 216.36 243.93 289.47 330.91 373.57 416.58 Gross Block 641.54 777.14 890.30 922.26 914.18 907.16 902.43 898.34 895.47 896.07 Accumulated Depreciation 506.70 624.55 708.20 730.96 697.82 663.23 612.96 567.43 521.90 479.49 Non Current Assets 313.73 336.06 363.54 369.25 387.98 395.80 415.92 454.30 496.93 539.79 Capital Work in Progress 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Non Current Investment 118.78 117.69 117.69 117.69 117.69 117.94 117.94 121.81 121.81 121.91 Long Term Loans & Adv. 59.83 65.49 63.47 59.41 53.92 33.93 8.51 1.58 1.55 1.30 Other Non Current Assets 0.28 0.28 0.27 0.85 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 348.26 283.33 227.11 178.56 146.88 104.41 91.97 87.20 85.78 76.07 Current Investments 0.00 0.02 0.22 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 132.47 90.84 73.94 62.50 40.82 35.36 32.91 36.75 38.01 33.61 Sundry Debtors 121.41 121.96 110.22 83.10 80.35 48.45 40.09 36.59 33.13 27.73 Cash & Bank 38.03 31.98 5.70 6.75 3.63 8.60 8.07 4.72 3.96 2.34 Other Current Assets 56.35 7.72 5.49 4.55 22.08 12.00 10.90 9.14 10.68 12.39 Short Term Loans & Adv. 50.45 30.80 31.53 21.67 16.27 8.89 7.94 6.56 9.00 9.61 Net Current Assets 18.88 -37.49 -95.10 -129.63 -3.91 -10.03 -7.61 -20.52 -21.91 -27.67 Total Assets 661.99 619.39 590.65 547.81 534.86 500.21 507.89 541.50 582.71 615.86

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 284.06 253.09 225.94 196.26 300.28 287.48 297.11 299.88 320.40 344.05 Share Capital 89.96 89.96 89.96 89.96 209.61 209.61 209.61 209.61 209.61 209.61 Total Reserves 194.10 163.13 135.98 106.30 90.67 77.87 87.50 90.27 110.79 134.44 Non-Current Liabilities 28.42 23.38 20.20 17.80 57.47 74.00 84.65 103.91 122.05 135.01 Secured Loans 0.92 1.83 2.95 1.38 43.41 62.27 74.78 94.65 98.85 114.37 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 15.04 14.32 Long Term Provisions 23.82 19.01 14.42 13.59 11.34 9.22 7.82 7.17 5.73 3.90 Current Liabilities 351.44 339.17 340.12 324.86 166.56 127.92 108.14 102.73 104.95 102.78 Trade Payables 172.30 168.15 174.88 124.88 115.33 84.96 68.60 56.81 64.98 59.79 Other Current Liabilities 165.06 160.64 163.90 198.65 47.04 39.87 37.58 45.22 38.96 41.11 Short Term Borrowings 11.36 8.99 0.00 0.00 0.00 2.23 1.19 0.00 0.00 0.00 Short Term Provisions 2.72 1.39 1.33 1.33 4.19 0.86 0.77 0.70 1.01 1.88 Total Liabilities 663.46 615.18 585.81 538.29 523.68 489.00 489.50 506.09 546.98 581.40 Net Block 216.37 236.21 264.29 271.80 296.72 322.48 368.08 409.46 451.86 496.02 Gross Block 752.55 887.76 997.60 1,026.96 1,018.43 1,009.35 1,004.61 1,000.44 997.38 997.96 Accumulated Depreciation 536.18 651.55 733.31 755.15 721.72 686.87 636.53 590.98 545.52 501.94 Non Current Assets 291.29 315.71 342.37 346.34 366.53 374.42 393.18 415.00 457.37 501.38 Capital Work in Progress 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Non Current Investment 1.08 0.00 0.00 0.00 0.00 0.00 0.00 3.87 3.87 3.97 Long Term Loans & Adv. 73.55 79.22 77.81 73.69 69.82 51.94 25.10 1.67 1.64 1.39 Other Non Current Assets 0.28 0.28 0.27 0.85 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 372.18 299.47 243.44 191.95 157.15 114.58 96.32 91.09 89.61 80.02 Current Investments 0.00 0.02 0.22 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 138.48 94.20 76.89 64.66 42.14 37.11 33.30 37.05 38.66 34.70 Sundry Debtors 137.68 133.75 121.85 92.95 87.94 56.14 42.67 39.11 35.15 29.64 Cash & Bank 38.88 32.21 5.95 7.59 4.36 8.85 9.11 5.53 4.51 2.58 Other Current Assets 57.14 7.86 5.62 4.71 22.71 12.48 11.24 9.40 11.29 13.10 Short Term Loans & Adv. 51.16 31.43 32.92 22.03 16.77 9.34 8.23 6.23 9.60 10.30 Net Current Assets 20.73 -39.70 -96.68 -132.92 -9.41 -13.34 -11.82 -11.64 -15.34 -22.76 Total Assets 663.47 615.18 585.81 538.29 523.68 489.00 489.50 506.09 546.98 581.40

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 10.86 14.58 61.25 49.24 50.01 50.74 33.19 33.46 26.77 9.67 PBT 37.48 28.61 26.12 22.55 20.04 0.72 -9.06 -25.75 -36.20 -43.73 Adjustment 34.23 38.36 37.86 40.92 45.32 47.22 55.66 56.73 54.84 52.00 Changes in Working Capital -55.33 -52.40 -2.72 -14.23 -11.09 2.94 -16.31 -0.60 -3.91 0.65 Cash after chg. in Working capital 16.38 14.58 61.25 49.24 54.27 50.88 30.29 30.38 14.73 8.92 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -5.52 0.00 0.00 0.00 0.14 -0.14 0.00 0.00 0.00 0.75 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 -4.40 0.00 2.90 3.08 12.04 0.00 Cash From Investing Activity -12.08 -10.34 -24.28 -14.67 -27.08 -30.22 -0.65 -2.51 -3.34 -3.85 Net Fixed Assets 135.60 113.16 31.96 -8.08 -7.02 -4.73 -4.09 -2.87 0.60 -2.41 Net Investments -1.07 0.20 -0.22 0.00 0.25 0.00 3.87 0.00 0.10 0.00 Others -146.61 -123.70 -56.02 -6.59 -20.31 -25.49 -0.43 0.36 -4.04 -1.44 Cash from Financing Activity 4.65 -0.35 -37.67 -31.29 -27.89 -19.99 -29.19 -30.19 -21.81 -4.30 Net Cash Inflow / Outflow 3.43 3.89 -0.69 3.29 -4.97 0.53 3.35 0.76 1.62 1.52 Opening Cash & Equivalents 9.36 5.47 6.16 2.87 8.60 8.07 4.72 3.96 2.34 0.82 Closing Cash & Equivalent 12.79 9.36 5.47 6.16 3.63 8.60 8.07 4.72 3.96 2.34

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 11.02 17.37 63.41 40.73 50.07 50.70 33.52 33.64 27.11 11.13 PBT 39.11 29.18 29.77 23.04 17.06 2.28 -5.64 -23.60 -35.61 -47.62 Adjustment 36.63 40.32 38.64 41.40 45.69 47.32 55.76 56.80 55.99 54.44 Changes in Working Capital -58.84 -51.78 -5.00 -23.72 -8.41 1.23 -19.50 -2.64 -5.25 3.63 Cash after chg. in Working capital 16.89 17.71 63.41 40.73 54.34 50.83 30.62 30.56 15.13 10.45 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -5.88 -0.34 0.00 0.00 0.13 -0.13 0.01 0.01 -0.06 0.68 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 -4.40 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -12.46 -13.05 -26.93 -13.60 -27.30 -31.65 -0.80 -2.83 -3.35 -4.05 Net Fixed Assets 135.60 113.16 31.96 -8.08 -7.02 -4.73 -4.09 -2.87 0.60 -2.41 Net Investments -1.07 0.20 -0.22 0.00 0.25 0.00 3.87 0.00 0.10 0.00 Others -146.99 -126.41 -58.67 -5.52 -20.53 -26.92 -0.58 0.04 -4.05 -1.64 Cash from Financing Activity 5.49 -0.44 -37.77 -23.72 -27.26 -19.31 -29.14 -29.79 -21.83 -5.60 Net Cash Inflow / Outflow 4.04 3.88 -1.29 3.40 -4.49 -0.26 3.58 1.02 1.93 1.48 Opening Cash & Equivalents 9.60 5.72 7.00 3.60 8.85 9.11 5.53 4.51 2.58 1.10 Closing Cash & Equivalent 13.64 9.60 5.72 7.00 4.36 8.85 9.11 5.53 4.51 2.58

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 6.83 6.17 5.57 4.99 4.65 4.30 4.55 4.69 5.19 5.73 ROA 5.05% 4.73% 4.59% 4.28% 3.05% 0.12% -1.17% -4.03% -4.03% -6.81% ROE 11.06% 10.84% 11.00% 10.69% 7.84% 0.29% -2.97% -10.21% -9.84% -15.44% ROCE 9.29% 7.74% 9.26% 9.17% 6.60% 2.32% 0.87% -2.42% -3.29% -7.02% Fixed Asset Turnover 1.12 0.86 0.62 0.60 0.51 0.42 0.38 0.34 0.31 0.25 Receivable days 56.08 59.08 62.91 54.48 50.93 42.76 41.07 41.14 40.65 40.17 Inventory Days 51.46 41.93 44.40 34.44 30.13 32.97 37.31 44.11 47.84 53.30 Payable days 79.07 88.97 104.24 84.35 83.75 77.64 70.84 71.22 76.97 97.16 Cash Conversion Cycle 28.47 12.04 3.07 4.58 -2.69 -1.90 7.54 14.02 11.52 -3.69 Total Debt/Equity 0.43 0.47 0.53 0.22 0.20 0.26 0.27 0.34 0.34 0.35 Interest Cover 20.05 14.82 7.08 4.10 2.50 1.08 0.38 -0.95 -2.04 -6.02

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 6.32 5.63 5.02 4.36 4.02 3.73 3.95 4.01 4.46 4.99 ROA 5.25% 4.80% 5.30% 4.45% 2.53% 0.44% -0.55% -3.90% -4.19% -7.84% ROE 12.50% 12.04% 14.10% 12.54% 7.35% 1.24% -1.54% -10.77% -11.12% -18.99% ROCE 10.25% 10.01% 14.05% 10.18% 6.29% 2.90% 1.80% -2.09% -3.40% -8.22% Fixed Asset Turnover 1.04 0.82 0.60 0.58 0.49 0.41 0.37 0.33 0.29 0.23 Receivable days 58.07 60.70 64.63 55.44 53.22 44.17 40.16 40.83 40.35 42.17 Inventory Days 49.78 40.63 42.59 32.73 29.27 31.48 34.55 41.63 45.68 52.36 Payable days 79.06 88.85 103.38 82.97 83.88 76.01 67.69 69.30 75.59 101.91 Cash Conversion Cycle 28.78 12.48 3.85 5.20 -1.39 -0.36 7.02 13.16 10.44 -7.39 Total Debt/Equity 0.47 0.52 0.06 0.25 0.22 0.28 0.30 0.37 0.38 0.39 Interest Cover 20.71 14.83 7.83 4.13 2.21 1.26 0.72 -0.77 -1.96 -6.59

Top Investors:

pinfold overseas limited

ferry holdings limited

damodar prasad agarwal

morepen laboratories ltd

Annual Reports:

News Update:

Morepen Laboratories incorporates wholly owned subsidiary company
7th Sep 2021, 15:58 PM

The company has incorporated a wholly owned subsidiary namely ‘Morepen Devices’on September 06, 2021
Read More
Morepen Laboratories, RDIF start production of test batch of Sputnik V in India
6th Jul 2021, 14:05 PM

The first batch will be shipped to the Gamaleya Center for the quality control
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback